Loading…
INCR
Intercure Ltd.
NASDAQ· Healthcare· Drug Manufacturers - Specialty & Generic· CUSIP M549GJ111
$5.78+1.76%Price as of Aug 29, 18:42 UTC · updated once a day, after the close
Key metrics
- Market cap
- $86.72M
- P/E
- —
- Forward P/E
- —
- P/B
- 0.8x
- Dividend yield
- —
- Payout
- —
- EPS
- -$1.11
- ROE
- -9.27%
- Profit margin
- -13.22%
- Revenue growth
- +23.90%
- Beta
- 0.57
- 52-week high
- $8.45
- 52-week low
- $3.40
History
How the company evolved, year by year. Revenue and debt come from the annual reports — for most companies, the 10-K filings with the SEC since 2009; dividends from the payments themselves.
The bars are a balance on the closing date; the lines are what happened during the year. Revenue above equity is ordinary, not an anomaly — it means the company turns its capital over more than once a year.
Investors holding this
Major managers that reported this stock in their latest 13F.
Price over time
▼ -84.6% over 5Y.
today you would have $150.36▼ -85.0%
Dividends reinvested, splits accounted for. Past prices say what happened, not what will.
Indicators, year by year
The last 4 closed years. Each multiple uses that year’s closing price and that year’s reported numbers — not today’s. The range is set by the annual reports on record.
| Indicator | Median | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Year-end price | $4.55 | $7.95 | $6.45 | $16.50 | |
| P/E | — | — | — | — | 16.7x |
| P/S | 1.2x | 0.9x | 1.6x | 0.8x | 1.9x |
| P/B | 0.8x | 0.6x | 0.9x | 0.6x | 1.5x |
| EPS | — | — |
Fair price, seven ways
Seven formulas applied to what the company reported. None of them predicts a price — each answers what the stock would be worth if its assumption held. The assumption is printed next to every number, because it is the assumption that produces the result.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Earnings
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Cash flow
$1.49
Cash flow growing 5.0% a year for 10 years, discounted at 10%, then 2.5% forever.
Operating
—
This formula has no meaning here — usually a loss, negative cash flow, or a missing input.
Others in the same sector
Companies of similar size in Healthcare, for comparison. The columns are the same ones above, in the same order.
| Stock | Price | P/E | P/B | Dividend yield | ROE | Market cap |
|---|---|---|---|---|---|---|
| ECORelectroCore, Inc. | $9.63 | — | — | — | — | $86.78M |
| OKYOOKYO Pharma Ltd | $1.67 | — | 7.1x | — | -263.78% | $87.64M |
| ACETAdicet Bio, Inc. | $9.15 | — | 0.8x | — | -78.08% | $85.61M |
| GUTSFractyl Health Inc | $0.55 |
About the company
InterCure Ltd., together with its subsidiaries, engages in the production, manufacturing, and distribution of pharmaceutical-grade cannabis and cannabis-based products for medical use in Israel and internationally. The company offers dried cannabis inflorescences and cannabis extract mixed with oil. It also invests in the biomed sector. The company was incorporated in 1994 and is headquartered in Herzliya, Israel.
- 285
- Herzliya, Israel
Company description provided by Yahoo Finance.